Category | Overall Patient | |||
---|---|---|---|---|
N (%) | Estimated Mean | Estimated Mean Ratio with 95% CI | P-valuea | |
Total Cost (PPPM) | ||||
Treated Patients | 1,699,913 (100.0%) | $967 | 2.13 (2.12, 2.13) | < .001 |
Matched Control Cohort | 1,603,929 (94.4%) | $455 | ||
Medical Cost (PPPM) | ||||
Inpatient Costs | ||||
All patients | ||||
Treated Patients | 315,679 (18.6%) | $1,912 | 1.25 (1.24, 1.26) | < .001 |
Matched Control Cohort | 83,826 (4.9%) | $1,529 | ||
Patients with no fallb or MVA eventsc | ||||
Treated Patients | 226,035 (13.3%) | $1,761 | 1.21 (1.20, 1.22) | < .001 |
Matched Control Cohort | 66,618 (3.9%) | $1,454 | ||
Patients with 1 + fallb | ||||
Treated Patients | 87,298 (5.1%) | $2,343 | 1.27 (1.25, 1.29) | < .001 |
Matched Control Cohort | 16,602 (1.0%) | $1,848 | ||
ED Costs | ||||
All patients | ||||
Treated Patients | 374,441 (22.0%) | $134 | 1.39 (1.38, 1.39) | < .001 |
Matched Control Cohort | 146,947 (8.6%) | $97 | ||
Patients with no fallb or MVA eventsc | ||||
Treated Patients | 256,246 (15.1%) | $125 | 1.32 (1.31, 1.33) | < .001 |
Matched Control Cohort | 111,059 (6.5%) | $94 | ||
Patients with 1 + fallb | ||||
Treated Patients | 113,905 (6.7%) | $158 | 1.49 (1.47, 1.50) | < .001 |
Matched Control Cohort | 34,016 (2.0%) | $106 | ||
Outpatient Costs | ||||
All patients | ||||
Treated Patients | 868,655 (51.1%) | $292 | 1.82 (1.81, 1.83) | < .001 |
Matched Control Cohort | 595,020 (35.0%) | $161 | ||
Patients with no fallb or MVA eventsc | ||||
Treated Patients | 727,581 (42.8%) | $279 | 1.81 (1.80, 1.82) | < .001 |
Matched Control Cohort | 552,413 (32.5%) | $154 | ||
Patients with 1 + fallb | ||||
Treated Patients | 136,150 (8.0%) | $380 | 1.51 (1.49, 1.54) | < .001 |
Matched Control Cohort | 40,523 (2.4%) | $251 |